Trade MMED stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
MiniMed Group, Inc. (MMED) is trading at US$21.79, down 1.09% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$5.74B. Over the past 52 weeks, MMED has traded between US$10.65 and US$28.00. On Syfe you can trade MMED with $0 commission and add it to your watchlist.
| Previous close | US$22.03 |
|---|---|
| Market cap | US$5.74B |
| P/E ratio | 32.78 |
| 52-week range | US$10.65 – US$28.00 |
| Volume | 2.88M |
| Exchange | US |
Add to Watchlist
Set Price Alert
MiniMed Group, Inc.
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
Year: 2026
MiniMed Group, Inc. (MMED) stock is trading at US$21.79, -1.09% from the previous close of US$22.03.
The market cap for MiniMed Group, Inc. (MMED) stock is approximately US$5.74B.
The price-to-earnings ratio for MiniMed Group, Inc. (MMED) is 32.78, based on the latest reported earnings.
The 52-week high for MiniMed Group, Inc. (MMED) stock is US$28.00.
The 52-week low for MiniMed Group, Inc. (MMED) stock is US$10.65.
MiniMed Group, Inc. (MMED) does not currently pay a dividend.
Stay on top of MMED
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
